Long-term prognosis of severe cutaneous adverse drug reaction

Long-term prognosis of severe cutaneous adverse drug reaction - Long-term prognosis of severe cutaneous adverse drug reaction

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009710

Enrollment

100

Registered

2013-01-07

Start date

2013-01-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stevens-Johnson syndrome Toxic epidermal necrolysis Drug-induced hypersensitivity syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Stevens-Johnson syndrome, toxic epidermal necrolysis or drug-induced hypersensitivity syndrome

Exclusion criteria

Exclusion criteria: Patients regarded as inadequate

Design outcomes

Primary

Measure	Time frame
Long term prognosis by interview form	—

Countries

Japan

Contacts

Public ContactTomoya Watanabe

Yokohama City University Graduate School of Medicine Environmental Immuno-Dermatology

nabetomo0968@yahoo.co.jp045-787-2675

Outcome results